Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer-Reference-Cited by-同舟云学术

Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer

Published:2016-07-15 Issue:15 Volume:76 Page:1375-1386
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Dai Liping¹,Li Jitian¹,Xing Mengtao¹,Sanchez Tino W.²,Casiano Carlos A.²³,Zhang Jian-Ying¹

Affiliation:

1. Department of Biological Sciences; The University of Texas at El Paso; El Paso Texas

2. Center for Health Disparities and Molecular Medicine; Department of Basic Sciences; Loma Linda University School of Medicine; Loma Linda California

3. Division of Rheumatology; Department of Medicine; Loma Linda University School of Medicine; Loma Linda California

Funder

National Institutes of Health (NIH)

Publisher

Wiley

Subject

Urology,Oncology

Reference59 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

3. Health disparities and cancer: Racial disparities in cancer mortality in the United States, 2000-2010;O'Keefe;Front Public Health,2015

4. Reducing prostate cancer racial disparity: Evidence for aggressive early prostate cancer PSA testing of African American men;Powell;Cancer Epidemiol Biomarkers Prev,2014

5. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity;Powell;J Urol,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NPM3 as an Unfavorable Prognostic Biomarker Involved in Oncogenic Pathways of Lung Adenocarcinoma via MYC Translational Activation;Combinatorial Chemistry & High Throughput Screening;2024-02

2. Genetic and biological drivers of prostate cancer disparities in Black men;Nature Reviews Urology;2023-11-14

3. Identification of Immunogenic Proteins in Early and Advanced Stages of Breast Cancer: An Immunoproteomics Study;MIDDLE EAST J CANCER;2023

4. Prostate Region-Wise Imaging Biomarker Profiles for Risk Stratification and Biochemical Recurrence Prediction;Cancers;2023-08-18

5. A Luminex Approach to Develop an Anti-Tumor-Associated Antigen Autoantibody Panel for the Detection of Prostate Cancer in Racially/Ethnically Diverse Populations;Cancers;2023-08-11